Buy Day today: Good (67) Broad market participation · no major macro event

Insulet Corporation (PODD)

Healthcare Medical Devices

169.70 $

+2.6% vs. previous close

Closing price · As of: 3. Aug 2026

Insulet Corporation (PODD) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Revenue" came in at 762 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow

Annual Quarterly

All figures in millions of USD.

Income Statement PODD
Tick rows to compare them in a chart (up to 4)	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	LTM
Revenue	397	433	510	442	489	544	598	569	649	706	784	762	2,901
Cost of Revenue	132	139	149	135	158	167	167	160	197	196	215	233	841
Gross Profit	265	293	361	307	331	377	431	409	452	510	569	529	2,060
Research & Development	55	58	42	50	54	55	61	60	73	77	91	90	331
Selling, General & Administrative	179	168	191	190	222	206	237	241	258	315	331	317	1,222
Total Operating Expenses	234	239	255	250	276	289	322	320	331	392	422	407	1,553
Operating Income	31	55	106	57	55	88	109	89	121	118	146	122	507
Interest Expense	9.7	10	6.7	11	11	12	8.7	9.2	20	16	20	15	70
Pre-Tax Income	29	54	108	55	51	83	111	48	28	123	140	113	404
Income Tax Expense	1.2	1.8	4.5	3.4	-138	5.4	11	13	5.9	35	39	22	102
Net Income	27	52	103	52	189	78	101	35	23	88	102	91	303
EBITDA	56	83	133	84	81	117	142	79	70	160	190	154	575

LTM = last twelve months (sum of the four most recent quarters).

Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Cookie settings